Best Practice Guidelines

The following best practice guidelines have been compiled as resources for physicians and other clinicians in an effort to promote accurate prescribing and improve the quality of treatment for persons in recovery.

Supporting Recovery from Opioid Addiction: Community Care Best Practice Guidelines for Recovery-Oriented Methadone Maintenance

Integrates recovery-oriented principles with the latest consensus practice guidelines and a phased-based approach:

  • Phase 1: Recovery Initiation and Stabilization
  • Phase 2: Early Recovery and Rehabilitations
  • Phase 3: Recovery Maintenance
  • Phase 4: Long-Term Sustained Recovery
  • General Agency Guidelines

"The recently released Community Care Best Practice Guidelines represent a major advance in the medication-assisted treatment of opioid dependence. I will link to them on my website this coming month and further disseminate them to interested parties. I get innumerable requests about how to increase the recovery orientation of medication-assisted treatment. The Community Care Guidelines will be helpful to many communities seeking this goal. Thank you for your hard work and leadership in this critical arena."

William White, MA
Emeritus Senior Research Consultant
Chestnut Health Systems

Click here to download the guidelines

Supporting Recovery from Opioid Addiction: Best Practice Guidelines for Buprenorphine and Suboxone®

Includes best practices for:

  • Screening, assessing, provision, and discontinuation of buprenorphine and Suboxone®.
  • Screening, assessing, and concurrent provision of the appropriate psychosocial treatment utilizing best practice approaches.
  • Screening, assessing, and concurrent addressing of co-occurring mental health issues.
  • Provision of a menu of community-based recovery support and wellness services, and activities as necessary to enhance and support recovery.

Click here to download the guidelines

Management of Benzodiazepines in Medication-Assisted Treatment

These best practices are divided into seven categories:

  • General guidelines
  • Assessment for MAT
  • Addressing benzodiazepine use
  • MAT for patients with concurrent benzodiazepine use
  • Noncompliance with treatment agreement
  • Risk management/impairment assessment
  • Special circumstances

Click here to download the guidelines